LDS/Medical Tests/Pregnancy Associated Plasma Protein-A (PAPP-A)

Pregnancy Associated Plasma Protein-A (PAPP-A)

PAPP-A (Pregnancy associated plasma protein A) is a glycoprotein that is produced by the formation of the placenta during pregnancy. Because PAPP-A levels increase with gestational age, serum PAPP-A analysis is known to be a useful diagnostic tool for prenatal screening for Down syndrome and other chromosomal abnormalities such as Trisomy 18. The PAPP-A concentration will quickly increase after the 7th week of gestation. Decreased levels in the first trimester can aid in the diagnosis of 90% of Down syndrome pregnancies when used in conjunction with maternal age, hCG levels, and ultrasound gestational age determination. Low first trimester maternal serum levels are also found with other fetal chromosomal abnormalities. Maternal serum screens that include PAPP-A, hCG, and nuchal translucency (NT) are available if physicians suspect Down’s syndrome or Trisomy 18, family history is present, or if the pregnant female is at older age (older than 35 years of age). A positive result indicates that the result is higher than the cutoff ratio but does not always provide a diagnosis. A positive test result indicates that more tests may need to be performed such as an amniotic fluid analysis.

  • Screening for Down syndrome
  • Screening for other fetal chromosomal abnormalities, primarily Trisomy 18

Decreased in:

  • PAPP-A values are reduced in the first trimester of Down’s Syndrome pregnancies
  • The values may appear normal in the second and third trimester, so testing during first trimester is essential
  • Low levels of PAPP-A are also seen in hypertension

Increased in:

  • Acute coronary syndrome

Serum

Group mU/L
Male & Non-pregnant females 3.8–10.4

 

Pregnancy — Serum (Weeks of Gestation)
Week mU/L
8 90–7000
9 <10–5800
10 140–7000
11 575–7250
12 900–9000
13 550–11,500
14 2200–39,500

Values decrease rapidly postpartum; they become undetectable within a few days to 3–5 weeks.

 

Amniotic Fluid (Weeks of Gestation)
Week mU/L
8 <10–64
9 <10–22.5
10 <10–210
11 <10–16.5
12 <10–15
13 <10–23
14 <10–110
17 <10–2135
Solid phase enzyme linked immunosorbent assay (ELISA).

Serum Red top preferred, Serum gel (SST) acceptable, Amniotic Fluid.

Stability

  • Ambient: 72 hours
  • Refrigerated: 7 days
  • Frozen: 6 months at -70°C
ß-hCG, Inhibin A, Alpha-fetoprotein, Unconjugated Estriol, First trimester Screening, Chromosomal Analysis from Amniotic Fluid, Chromosomal Analysis from Chorionic Villous Sampling.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • J Obstet Gynaecol Can. 2008 Oct;30(10):918-49. [PMID: 19038077]
  • Scand J Clin Lab Invest. 2003;63(6):407-15. [PMID: 14594321]
  • Semin Perinatol. 2005 Aug;29(4):267-71. [PMID: 16104680]
  • Bratisl Lek Listy. 2002;103(6):194-205. [PMID: 12448565]
  • First Trimester Maternal Screen, Serum. In Mayo Interpretive Handbook. Rochester: Mayo Medical Laboratories (2009)
  • Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757